-
Hikal's API Manufacturing Site In Bangalore Completes 3rd Successful US FDA Inspection.
2/10/2012
Hikal Limited, a leading manufacturer of active ingredients, intermediates and regulated starting materials successfully completed its 3rd US FDA audit at its manufacturing facility located at Jigani, Bangalore.
-
NextPharma Technologies Hosts Inauguration Ceremony To Mark Official Opening Of Its 'State Of The Art' Cold Chain And Logistics Warehouse In Werne, Germany
2/3/2012
NextPharma, the leading European provider of product development, contract manufacturing and cold chain and logistics outsourcing services to the pharmaceutical
and biotechnology industries, is pleased to announce the official opening of its "state of the art" Cold Chain and Logistics (CLS) warehouse in Werne, Germany at an inauguration ceremony attended by local dignitaries and many of NextPharma's customers.
-
OctoPlus Enters Into Drug Development And Manufacturing Contract With Ferring Pharmaceuticals A/S
2/3/2012
OctoPlus N.V. ("OctoPlus" or the "Company") (Euronext: OCTO), announces today that a formulation development and manufacturing contract has been signed with Ferring Pharmaceuticals A/S, a leading innovative pharmaceutical company.
-
Encap Drug Delivery Adds New Commercial Product To Portfolio
2/1/2012
Encap Drug Delivery, the world’s leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, announces the addition of a further pharmaceutical product to its portfolio of commercial products.
-
Aptar Pharma Expands Presence In India With A New Manufacturing Site Near Mumbai
1/25/2012
Aptar Pharma, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices, recently announces the opening of a new facility near Mumbai, India.
-
Nanohale AG Acquires R&D And Service Units Of Scil Technology GmbH: Transaction Creates New Nanohale Subsidiary Named Formycon GmbH
1/17/2012
Scil Technology GmbH and Nanohale AG today announced that Nanohale has acquired the entire R&D, contract development and manufacturing organization of Scil Technology GmbH in an asset deal, effective December 31, 2011.
-
Toray To Take Equity Stake In Mitsui Subsidiary MicroBiopharm Japan Co., Ltd.
1/11/2012
Toray Industries, Inc. (“Toray”; head office: Tokyo; President, CEO and COO: Akihiro Nikkaku) and Mitsui & Co., Ltd.
-
AstraZeneca To Acquire Generics Company To Broaden Patient Access To Medicines In China
12/13/2011
AstraZeneca recently announced it has entered into an agreement to acquire Guangdong BeiKang Pharmaceutical Company Ltd, a privately-owned generics manufacturing company, based in Conghua City, Guangdong province, China.
-
ICON Acquires BeijingWits Medical Consulting Ltd
12/13/2011
ICON Plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries,recently announced that it has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China.
-
Catalent Announces Plans To Increase Biologic Development And Manufacturing Capabilities
12/12/2011
Catalent Pharma Solutions, a leading provider of drug and biologic development services, delivery technologies and supply solutions, announces plans to expand its biologics facility by relocating to a new facility in Madison, Wisconsin in late 2012 to provide increased capacity for seamless cell line and biomanufacturing solutions for innovators to speed time to clinic.
